Longevity & NAD+ Restoration Stack: Scientific Analysis of Synergistic Anti-Aging Mechanisms
Targeting five hallmarks of aging through NAD+ repletion, sirtuin activation, senolytic activity, mitochondrial support, and AMPK signaling. Six compounds, one integrated protocol built on preclinical evidence and emerging human data.
A Mechanistically Sound Multi-Hallmark Longevity Stack With Emerging — But Incomplete — Human Evidence
This six-compound stack targets NAD+ decline, sirtuin inactivation, mitochondrial dysfunction, cellular senescence, oxidative damage, and metabolic dysregulation. The mechanistic logic is strong: NMN/NR restores NAD+, resveratrol activates SIRT1 (which requires NAD+ as a co-substrate), berberine activates AMPK and amplifies NAD+ biosynthesis, quercetin clears senescent cells, CoQ10 maintains mitochondrial electron transport chain function, and astaxanthin provides membrane-level antioxidant protection. Each compound addresses a distinct hallmark of aging while synergizing with others.
The honest caveat: most longevity evidence is preclinical. No human lifespan data exists for any of these compounds. We extrapolate from biomarker improvements — NAD+ levels, inflammatory markers, mitochondrial function, metabolic health — that are associated with healthier aging in observational data and animal models. The stack is also the most expensive protocol in our analysis. Prioritize exercise, sleep, and nutrition first.
Stack Overview & Rationale — Why Multi-Compound Longevity
The Hallmarks of Aging This Stack Targets
Biological aging is not a single process. In 2013, Lopez-Otin and colleagues published a landmark paper in Cell identifying nine hallmarks of aging — interconnected mechanisms that drive the decline of physiological function over time. This stack directly targets six of those hallmarks:
- NAD+ Decline: NAD+ levels fall by approximately 50% between age 40 and 60. NAD+ is essential for over 500 enzymatic reactions including DNA repair (PARPs), epigenetic regulation (sirtuins), and cellular energy metabolism. Its decline is upstream of many other aging processes.
- Sirtuin Inactivation: Sirtuins (SIRT1-7) are a family of NAD+-dependent deacetylases that regulate DNA repair, mitochondrial biogenesis, inflammation, and stress resistance. Without adequate NAD+, sirtuin activity collapses — regardless of whether the sirtuin proteins themselves are present.
- Mitochondrial Dysfunction: Aging mitochondria accumulate mutations in their own DNA, lose electron transport chain efficiency, leak more electrons (generating reactive oxygen species), and decrease ATP output. This affects every organ, particularly the brain, heart, and skeletal muscle.
- Cellular Senescence: Damaged cells that stop dividing but refuse to die become "zombie cells." They secrete a cocktail of inflammatory cytokines, proteases, and growth factors known as the senescence-associated secretory phenotype (SASP) that damages neighboring healthy cells and drives chronic inflammation.
- Oxidative Damage: Cumulative oxidative damage to lipids, proteins, and DNA accelerates aging — particularly in mitochondrial membranes, which are both the primary source and primary target of reactive oxygen species.
- Metabolic Dysregulation: Age-related insulin resistance, impaired nutrient sensing, and dysregulated AMPK/mTOR signaling contribute to metabolic syndrome, inflammation, and accelerated aging. Caloric restriction — the only intervention consistently shown to extend lifespan across species — works largely through AMPK activation and mTOR inhibition.
Why No Single Compound Is Sufficient
The multi-factorial nature of aging means no single compound addresses all pathways. Raising NAD+ alone does not clear senescent cells. Clearing senescent cells alone does not restore mitochondrial function. Activating AMPK alone does not repair oxidative membrane damage. Each agent in this stack targets a distinct hallmark while creating synergistic amplification loops with other agents in the protocol.
The Honest Caveat: Most longevity evidence is preclinical — animal models and mechanistic studies. Human lifespan studies are essentially impossible to run (they would require decades of follow-up). What we can measure in humans are biomarkers: NAD+ levels, inflammatory markers, telomere length, epigenetic clocks, metabolic panels. Improvements in these biomarkers are associated with longer healthspan in observational data, but no supplement has been proven to extend human lifespan in a randomized controlled trial. This stack is built on the best available evidence — but intellectual honesty demands acknowledging the limits of that evidence.
graph TD A["Hallmarks of Aging
This Stack Targets"] --> B["NAD+ Decline"] A --> C["Sirtuin Inactivation"] A --> D["Mitochondrial
Dysfunction"] A --> E["Cellular
Senescence"] A --> F["Oxidative
Damage"] A --> G["Metabolic
Dysregulation"] B --> H["NMN / NR"] C --> I["Resveratrol"] D --> J["CoQ10"] E --> K["Quercetin"] F --> L["Astaxanthin"] G --> M["Berberine"] H -.->|"fuels"| C I -.->|"requires NAD+"| B M -.->|"upregulates NAMPT"| B J -.->|"reduces ROS source"| F L -.->|"protects membranes"| D style A fill:#e4e4e7,stroke:#2a2236,stroke-width:3px,color:#0a0a0a style H fill:#e4e4e7,stroke:#2a2236,stroke-width:2px,color:#0a0a0a style I fill:#e4e4e7,stroke:#2a2236,stroke-width:2px,color:#0a0a0a style J fill:#e4e4e7,stroke:#2a2236,stroke-width:2px,color:#0a0a0a style K fill:#e4e4e7,stroke:#2a2236,stroke-width:2px,color:#0a0a0a style L fill:#e4e4e7,stroke:#2a2236,stroke-width:2px,color:#0a0a0a style M fill:#e4e4e7,stroke:#2a2236,stroke-width:2px,color:#0a0a0a style B fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a style C fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a style D fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a style E fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a style F fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a style G fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a
Individual Compound Roles — Six Agents, Six Targets
NMN / NR — NAD+ Precursors
Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are direct precursors to NAD+ in the salvage pathway — the primary route through which cells recycle and maintain their NAD+ pool. NAD+ is not merely an energy currency; it is a critical substrate for sirtuins (epigenetic regulators), PARPs (DNA repair enzymes), and CD38 (immune signaling). When NAD+ declines with age, all three systems are starved of their essential co-factor.
NMN is phosphorylated to NAD+ by the enzyme NMNAT. NR is first phosphorylated to NMN by NR kinases, then converted to NAD+. Both raise cellular NAD+ levels in human studies — NMN increased blood NAD+ by 38-142% depending on dose in the Yi 2023 trial, and NR raised NAD+ metabolites by approximately 60% in the Martens 2018 study. The functional consequence: restored substrate availability for every NAD+-dependent enzyme in the cell.
Resveratrol — Sirtuin Activator (SIRT1)
Resveratrol is a polyphenolic stilbene found in grape skins, red wine, and Japanese knotweed. Its primary mechanism in the longevity context is allosteric activation of SIRT1 — the most studied sirtuin — which deacetylates targets involved in mitochondrial biogenesis (PGC-1alpha), inflammation (NF-kB), autophagy, and stress resistance. Resveratrol lowers the Km of SIRT1 for its substrates, making it more catalytically efficient.
The critical insight: SIRT1 requires NAD+ as a co-substrate. Activating SIRT1 with resveratrol is futile if the cell lacks NAD+. This is the foundation of the NMN + resveratrol synergy — NMN provides the fuel, resveratrol presses the accelerator. This is the core thesis of David Sinclair's longevity research at Harvard Medical School.
Quercetin — Senolytic Agent
Quercetin is a flavonoid found in onions, apples, and capers. In the longevity context, its most significant role is as a senolytic agent — a compound that selectively induces apoptosis in senescent cells. Research by Kirkland, Tchkonia, and colleagues at the Mayo Clinic demonstrated that quercetin (particularly in combination with the cancer drug dasatinib) clears senescent cells in mouse models, reducing the senescence-associated secretory phenotype (SASP) and extending healthspan.
Senescent cells accumulate with age and secrete pro-inflammatory cytokines (IL-6, IL-8, TNF-alpha), matrix metalloproteinases, and growth factors that damage neighboring tissue. Clearing even a small fraction of these cells has dramatic effects in animal models — improved physical function, reduced fibrosis, and extended lifespan. Quercetin alone is a weaker senolytic than the quercetin + dasatinib combination, but it provides meaningful senolytic activity alongside its well-documented anti-inflammatory and antioxidant properties.
CoQ10 (Ubiquinol) — Mitochondrial Electron Carrier
Coenzyme Q10 exists in two forms: ubiquinone (oxidized) and ubiquinol (reduced, active form). It functions as an essential electron carrier in the mitochondrial electron transport chain (ETC), shuttling electrons between Complex I/II and Complex III. Without adequate CoQ10, electrons leak from the ETC and react with oxygen to form superoxide — the primary source of mitochondrial reactive oxygen species.
Endogenous CoQ10 production peaks around age 20 and declines progressively. By age 80, cardiac CoQ10 levels are approximately 50% lower than at age 20. Supplementation with the ubiquinol form (which has 3-8x greater bioavailability than ubiquinone) maintains ETC efficiency, reduces electron leak at the source, and supports ATP production in high-demand tissues — heart, brain, skeletal muscle, and liver.
Astaxanthin — Membrane-Level Antioxidant
Astaxanthin is a xanthophyll carotenoid produced by the microalga Haematococcus pluvialis. It is one of the most potent lipid-soluble antioxidants measured — 6,000x stronger than vitamin C, 550x stronger than vitamin E, and 40x stronger than beta-carotene in singlet oxygen quenching assays. Unlike most antioxidants, astaxanthin spans the entire lipid bilayer of cell membranes, providing protection to both the inner and outer membrane surfaces simultaneously.
Critically, astaxanthin crosses the blood-brain barrier — allowing it to protect neuronal membranes and mitochondrial membranes in the central nervous system. It also accumulates in mitochondrial membranes, where it protects the very lipid environment in which CoQ10 operates. This creates a complementary layer: CoQ10 prevents ROS generation at the ETC source, while astaxanthin quenches any ROS that escapes and protects the membrane environment from oxidative damage.
Berberine — AMPK Activator and Caloric Restriction Mimetic
Berberine is an isoquinoline alkaloid extracted from plants in the Berberis genus. It activates AMP-activated protein kinase (AMPK) — the master metabolic sensor that cells use to detect low energy states. AMPK activation triggers a cascade of metabolic benefits: enhanced glucose uptake, improved insulin sensitivity, increased fatty acid oxidation, inhibition of mTOR (shifting from growth to repair), and upregulation of autophagy.
In the context of this stack, berberine's most important secondary effect is its upregulation of NAMPT — nicotinamide phosphoribosyltransferase, the rate-limiting enzyme in the NAD+ salvage pathway. By increasing NAMPT expression, berberine amplifies the body's capacity to convert nicotinamide back into NMN and then NAD+. This means berberine does not just mimic caloric restriction — it actively supports the NAD+ restoration that NMN/NR provide. Berberine is often called "natural metformin" because its metabolic effects overlap significantly with the prescription drug, which is itself under investigation as a longevity intervention in the TAME (Targeting Aging with Metformin) trial.
Mechanism of Synergy — The Multi-Layer Cascade
The individual compounds are valuable. The synergistic interactions between them are where the protocol logic becomes compelling. Each step amplifies or complements another.
NMN/NR Replenishes the NAD+ Pool
NAD+ levels decline by approximately 50% by age 60. This decline is driven by increased consumption (CD38 activity rises with age) and decreased synthesis (NAMPT activity falls). NMN and NR provide exogenous substrate to restore NAD+ toward youthful levels. Human trials confirm dose-dependent increases in blood and tissue NAD+ metabolites. This is the foundation of the entire stack — without adequate NAD+, sirtuins cannot function, PARPs cannot repair DNA, and mitochondrial metabolism is impaired.
Resveratrol Activates SIRT1 — But SIRT1 Requires NAD+
Resveratrol allosterically activates SIRT1, lowering its Km for acetylated substrates. But SIRT1 is an NAD+-dependent deacetylase — it literally consumes one molecule of NAD+ for every deacetylation reaction. In an NAD+-depleted cell (typical of aging), SIRT1 activation by resveratrol alone is limited by substrate availability. NMN ensures SIRT1 has the fuel it needs. This is the core Sinclair thesis: NMN is the gas, resveratrol is the accelerator pedal. Neither alone is as effective as both together.
Berberine Activates AMPK and Upregulates NAMPT
Berberine activates AMPK, which upregulates NAMPT — the rate-limiting enzyme in the NAD+ salvage pathway. NAMPT converts nicotinamide (the byproduct of sirtuin and PARP activity) back into NMN, which is then converted to NAD+. This creates a feed-forward loop: NMN raises NAD+, sirtuins consume NAD+ and produce nicotinamide, berberine-upregulated NAMPT recycles nicotinamide back to NMN, replenishing the pool. AMPK activation also inhibits mTOR — shifting cellular resource allocation from growth to repair and autophagy.
Quercetin Clears Senescent Cells and Reduces SASP
While the NAD+/sirtuin/AMPK axis restores cellular function in healthy cells, quercetin targets the cells beyond repair. Senescent cells that have accumulated DNA damage, telomere erosion, or oncogenic stress stop dividing but resist apoptosis through upregulated survival pathways (BCL-2, PI3K/AKT). Quercetin inhibits these survival pathways, tipping senescent cells toward programmed death. Clearing senescent cells reduces the SASP — the inflammatory secretome that accelerates aging in surrounding tissue. Lower SASP means less chronic inflammation, less tissue fibrosis, and a healthier microenvironment for the cells that NAD+ restoration is repairing.
CoQ10 Maintains Mitochondrial ETC Function
With NAD+ restored, sirtuins activated, AMPK engaged, and senescent cells cleared, the remaining healthy mitochondria need support. CoQ10 maintains electron transport chain efficiency by serving as the mobile electron carrier between Complex I/II and Complex III. This prevents electron leak — the primary source of mitochondrial ROS. By reducing ROS generation at the source, CoQ10 complements the NAD+/sirtuin axis: SIRT3 (activated by NAD+) promotes mitochondrial antioxidant defenses, and CoQ10 reduces the oxidative burden those defenses must handle.
Astaxanthin Protects Membranes From Residual Oxidative Damage
Even with optimized ETC function, some ROS generation is unavoidable — it is a byproduct of aerobic metabolism. Astaxanthin embeds within mitochondrial and cellular membranes, quenching singlet oxygen and peroxyl radicals before they can initiate lipid peroxidation chain reactions. This protects the very membrane environment in which CoQ10 operates and preserves mitochondrial membrane integrity. Astaxanthin's ability to cross the blood-brain barrier extends this protection to neuronal mitochondria — critical given that the brain consumes 20% of the body's oxygen despite representing only 2% of body mass.
graph LR A["NMN / NR
NAD+ Precursor"] -->|"restores"| B["NAD+ Pool"] B -->|"fuels"| C["SIRT1
Activated by Resveratrol"] C -->|"produces"| D["Nicotinamide
Byproduct"] D -->|"recycled by NAMPT"| A E["Berberine
AMPK Activator"] -->|"upregulates
NAMPT"| D E -->|"inhibits mTOR"| F["Autophagy
Repair Mode"] G["Quercetin
Senolytic"] -->|"clears"| H["Senescent Cells"] H -->|"reduces"| I["SASP
Inflammation"] J["CoQ10
ETC Support"] -->|"prevents"| K["Electron Leak
ROS Source"] L["Astaxanthin
Antioxidant"] -->|"quenches"| M["Residual ROS"] L -->|"protects"| N["Mitochondrial
Membranes"] style A fill:#e4e4e7,stroke:#2a2236,stroke-width:2px,color:#0a0a0a style C fill:#e4e4e7,stroke:#2a2236,stroke-width:2px,color:#0a0a0a style E fill:#e4e4e7,stroke:#2a2236,stroke-width:2px,color:#0a0a0a style G fill:#e4e4e7,stroke:#2a2236,stroke-width:2px,color:#0a0a0a style J fill:#e4e4e7,stroke:#2a2236,stroke-width:2px,color:#0a0a0a style L fill:#e4e4e7,stroke:#2a2236,stroke-width:2px,color:#0a0a0a style B fill:#f4f4f5,stroke:#8a7d68,stroke-width:1px,color:#0a0a0a style D fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a style F fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a style H fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a style I fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a style K fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a style M fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a style N fill:#f4f4f5,stroke:#a1a1aa,stroke-width:1px,color:#0a0a0a
"Aging is not a single disease — it is a constellation of interconnected failures. No single molecule fixes a constellation. You need a protocol that addresses multiple failure modes simultaneously, with compounds that amplify each other's effects."
Begin in the app
Share your biology. Receive a precision protocol routed through hundreds of cited compounds.
Dosing Protocol — Timing, Forms, and Cycling
Daily Protocol
Timing in this stack is driven by two principles: (1) NAD+ has a natural circadian rhythm that peaks in the morning, so NAD+ precursors are taken in the morning to align with this biology; and (2) several compounds in this stack are fat-soluble and require lipid co-ingestion for adequate absorption.
Critical Notes on Forms and Absorption
- Resveratrol bioavailability: Trans-resveratrol has extremely poor oral bioavailability — as low as 1-2% due to rapid glucuronidation in the gut and liver. Co-ingestion with a fat source (yogurt, olive oil, avocado, nuts) significantly improves absorption. David Sinclair has publicly stated he takes his resveratrol mixed into yogurt for this reason. Do not take resveratrol on an empty stomach.
- CoQ10 form matters: Ubiquinol (reduced form) has 3-8x greater bioavailability than ubiquinone (oxidized form). For anyone over 40, ubiquinol is the evidence-based form because the body's ability to reduce ubiquinone to ubiquinol declines with age.
- NMN sublingual: Sublingual delivery bypasses first-pass hepatic metabolism and may improve bioavailability. Some researchers and practitioners prefer sublingual NMN for this reason, though head-to-head pharmacokinetic data comparing sublingual vs. oral NMN in humans is limited.
- Berberine GI tolerance: Start at 500mg once daily with a meal and titrate up to 500mg 2-3x daily over 1-2 weeks. GI distress (cramping, diarrhea, nausea) is the most common side effect and is typically dose-dependent. Taking berberine with food substantially reduces GI symptoms.
Quercetin Cycling Protocol
The senolytic research community has proposed two approaches to quercetin dosing:
- Senolytic pulse dosing: 1000mg/day for 3 consecutive days, then 11-14 days off. This mimics the intermittent dosing schedule used in the Kirkland/Tchkonia senolytic research. The rationale is that senolytic activity requires acute, high-dose exposure to overwhelm senescent cell survival pathways — chronic low-dose exposure may trigger adaptive resistance.
- Daily anti-inflammatory dosing: 500mg/day continuously for general antioxidant and anti-inflammatory benefits, without the acute senolytic pulse. This approach sacrifices some senolytic potency but provides continuous NF-kB inhibition and quercetin's broad anti-inflammatory effects.
Either approach is reasonable. If senolytic activity is your primary goal, pulse dosing is more aligned with the research. If general anti-inflammatory support is the goal, daily dosing is simpler and still beneficial.
Cost Reality Check: NMN is $50-100/month alone at quality-tested doses. The complete six-compound stack runs $100-200/month depending on sourcing and dose. This is the most expensive protocol in the Protocols.is analysis. Before investing, ensure your foundations are solid: consistent exercise (the single most evidence-backed longevity intervention), 7-9 hours of quality sleep, whole-food nutrition, and stress management. Supplements without foundations is money wasted.
gantt title Morning Dosing Sequence & Monthly Quercetin Cycle dateFormat HH:mm axisFormat %H:%M section Morning Stack NMN or NR - sublingual/oral :a1, 07:00, 15m Resveratrol - with fat source :a2, 07:15, 15m Berberine - with breakfast :a3, 07:30, 30m CoQ10 + Astaxanthin - with meal fat :a4, 07:30, 30m section Midday Berberine - with lunch :b1, 12:30, 30m section Evening Berberine - with dinner (if 3x/day) :c1, 18:30, 30m
Clinical Evidence — What the Research Actually Shows
The Evidence Hierarchy for Longevity Compounds
Before reviewing individual compound evidence, a note on the evidence landscape. Longevity research operates under a fundamental constraint: you cannot run a human lifespan trial. The gold standard of medical evidence — the randomized controlled trial with a primary endpoint — is essentially impossible when the endpoint is "death from aging" and the follow-up period would be 40-60 years. What we have instead is a layered evidence base:
- Mechanistic studies (cell culture, enzymology) — establish biological plausibility
- Animal lifespan studies (mice, worms, flies) — demonstrate extension of lifespan in model organisms
- Human biomarker trials (RCTs measuring surrogate endpoints) — show improvements in markers associated with aging
- Observational/epidemiological data — correlate dietary intake or blood levels with longevity outcomes
Most compounds in this stack have strong evidence at layers 1-3. No compound has layer 4 evidence from interventional trials. We are honest about this.
NMN — Human Trial Evidence
Yi et al. (2023), Science: A 12-week RCT in 30 postmenopausal women with prediabetes showed 250mg/day NMN improved muscle insulin sensitivity by 25%, comparable to effects seen with exercise interventions. NAD+ metabolites in blood increased dose-dependently. This was the first rigorous human trial demonstrating functional metabolic improvements from NMN.
Igarashi et al. (2022), NPJ Aging: A safety and pharmacokinetics trial confirmed oral NMN (250mg/day) was safe and well-tolerated in healthy middle-aged men over 12 weeks, with significant increases in blood NAD+ metabolites and no adverse effects on liver, kidney, or cardiovascular markers.
Sinclair Lab animal data: NMN reversed age-related vascular dysfunction, improved insulin sensitivity, restored mitochondrial function, and improved endurance capacity in aged mice. The mouse data is extensive and consistent but — as with all animal data — direct translation to human longevity is uncertain.
NR (Nicotinamide Riboside) — Human Trial Evidence
Martens et al. (2018), Nature Communications: A 6-week crossover RCT in 24 lean, healthy middle-aged and older adults showed 1000mg/day NR raised NAD+ metabolites by approximately 60%, reduced systolic blood pressure by 2-4 mmHg, and improved arterial compliance (a measure of vascular aging). The blood pressure effect was most pronounced in individuals with elevated baseline blood pressure.
Dollerup et al. (2018), American Journal of Clinical Nutrition: A 12-week RCT in 40 obese, insulin-resistant men showed 2000mg/day NR was safe and raised NAD+ metabolites but did not significantly improve insulin sensitivity or body composition in this population. This is an important null result — NR does not work equally across all metabolic contexts.
Resveratrol — Human Trial Evidence
Timmers et al. (2011), Cell Metabolism: 150mg/day resveratrol for 30 days in 11 obese men mimicked caloric restriction effects — reduced intrahepatic lipid content, decreased inflammation (lower circulating levels of TNF-alpha and leukocytes), improved insulin sensitivity, and reduced systolic blood pressure. Metabolomic profiling showed a shift toward oxidative metabolism consistent with SIRT1/AMPK activation.
Moussa et al. (2017), Neurology: A Phase 2 trial in 119 patients with mild-to-moderate Alzheimer's disease showed 2g/day resveratrol (high dose) stabilized CSF amyloid-beta 40 levels and reduced MMP-9 — a biomarker of blood-brain barrier permeability and neuroinflammation. Brain volume declined less in the resveratrol group, though the clinical significance of this is debated.
Quercetin — Senolytic Evidence
Xu et al. (2018), Nature Medicine: The landmark Mayo Clinic study demonstrated that the combination of dasatinib (a cancer drug) + quercetin cleared senescent cells in aged mice, reduced SASP, improved physical function, and extended remaining lifespan by 36%. This is animal data, and dasatinib is a prescription oncology drug — but it established quercetin as a senolytic agent.
Kirkland & Tchkonia (2017), Journal of the American Geriatrics Society: The conceptual framework paper defining senolytics as a drug class. Quercetin was identified as one of the first natural senolytic compounds, effective against certain senescent cell types (particularly senescent endothelial cells and bone marrow stem cells).
Justice et al. (2019), EBioMedicine: A first-in-human pilot trial of dasatinib + quercetin in 14 patients with idiopathic pulmonary fibrosis showed the combination reduced senescent cell burden and improved physical function over 3 weeks. Small sample size, no control group — but proof-of-concept in humans.
CoQ10 — Human Trial Evidence
Alehagen et al. (2013), International Journal of Cardiology: A landmark 5-year RCT in 443 healthy elderly Swedish citizens showed that combined supplementation with CoQ10 (200mg/day) and selenium (200mcg/day) reduced cardiovascular mortality by 49% compared to placebo over 5 years. A 12-year follow-up published in 2018 showed the mortality benefit persisted even 8 years after supplementation ended. This is one of the strongest pieces of evidence for any supplement in cardiovascular aging.
Astaxanthin — Evidence Base
Kidd (2011), Alternative Medicine Review: A comprehensive review establishing astaxanthin's antioxidant potency, its ability to cross the blood-brain barrier, and its accumulation in mitochondrial membranes. Clinical evidence includes reductions in CRP, improvements in blood lipid profiles, and protection against exercise-induced oxidative damage.
Baralic et al. (2015), European Journal of Applied Physiology: A 90-day RCT in 40 soccer players showed 4mg/day astaxanthin reduced post-exercise levels of creatine kinase, 8-OHdG (a DNA oxidative damage marker), and pro-inflammatory cytokines compared to placebo.
Berberine — Human Trial Evidence
Yin et al. (2008), Metabolism: A 3-month RCT in 116 patients with type 2 diabetes showed 1000mg/day berberine reduced fasting blood glucose by 25.9%, HbA1c by 18.1%, and triglycerides by 27.4% — effects comparable to metformin in a head-to-head comparison arm. This established berberine as a legitimate glucose-lowering agent with clinical efficacy.
Zhang et al. (2008), Diabetes: Demonstrated that berberine activates AMPK through inhibition of mitochondrial Complex I — the same mechanism by which metformin activates AMPK. This provided the molecular basis for berberine's metabolic effects and its designation as a "natural metformin."
Honest Assessment: The compound-level evidence is meaningful but heterogeneous. CoQ10 has the strongest single trial (Alehagen 2013 — 49% cardiovascular mortality reduction). Berberine has head-to-head equivalence with a prescription drug. NMN and NR have promising but early human data. Resveratrol and quercetin have strong mechanistic and animal data with limited but encouraging human trials. Astaxanthin has solid antioxidant evidence but no longevity-specific human trials. Most critically: no human lifespan data exists for any of these compounds. We extrapolate from biomarker improvements. The stack is mechanistically sound. Whether it extends human life remains unknown.
| Compound | Key Trial | Primary Finding | Evidence Level |
|---|---|---|---|
| NMN | Yi 2023 (n=30, RCT) | 25% improved muscle insulin sensitivity | Emerging human |
| NR | Martens 2018 (n=24, RCT) | 60% NAD+ increase, reduced blood pressure | Moderate human |
| Resveratrol | Timmers 2011 (n=11) | Caloric restriction mimetic effects | Pilot human |
| Quercetin | Xu 2018 (mouse) / Justice 2019 (n=14) | Senescent cell clearance, 36% lifespan (mice) | Strong animal, pilot human |
| CoQ10 | Alehagen 2013 (n=443, RCT) | 49% reduced cardiovascular mortality over 5 yrs | Strong human |
| Astaxanthin | Baralic 2015 (n=40, RCT) | Reduced oxidative stress biomarkers | Moderate human |
| Berberine | Yin 2008 (n=116, RCT) | Glucose reduction comparable to metformin | Strong human |
Risk & Interaction Profile
Individual Compound Risk Assessment
NMN / NR — Generally Well-Tolerated
Human safety data for NMN and NR is reassuring. The Igarashi 2022 trial confirmed no adverse effects on liver, kidney, or cardiovascular markers at 250mg/day over 12 weeks. NR has been tested at doses up to 2000mg/day (Dollerup 2018) with acceptable safety profiles. Common side effects are mild: flushing, mild GI discomfort, and transient skin warmth (likely related to NAD+ metabolism).
Theoretical cancer concern: NAD+ fuels all cells, including potentially cancerous ones. Tumor cells upregulate NAD+ biosynthesis, and some tumor microenvironments have elevated CD38 activity. The concern is that exogenous NAD+ boosting could fuel existing, undetected cancers. However: NAD+ also fuels PARPs (DNA repair) and immune surveillance — both anti-cancer mechanisms. No human data shows increased cancer incidence from NMN or NR. The concern is debated in the field but has not materialized clinically. Individuals with active cancer should consult their oncologist.
Resveratrol — Mild Risk Profile
At doses up to 1000mg/day, resveratrol is generally well-tolerated. Potential concerns include: blood thinning at high doses (inhibits platelet aggregation — caution with anticoagulants), GI upset (nausea, diarrhea at doses above 2g/day), and weak estrogenic activity (resveratrol binds estrogen receptors at very low affinity — clinically insignificant at standard doses, but theoretically relevant for estrogen-sensitive conditions).
Quercetin — Monitor Thyroid Function
Quercetin is generally safe at doses up to 1000mg/day. The most significant concern is thyroid interaction: quercetin inhibits thyroid peroxidase (TPO) in vitro at high concentrations. In individuals with borderline hypothyroidism or those taking thyroid medication, chronic high-dose quercetin could theoretically impair thyroid hormone synthesis. Monitor TSH levels if supplementing long-term. Additional concerns: GI discomfort and potential interaction with certain antibiotics (quercetin can chelate metal ions, affecting fluoroquinolone absorption).
Berberine — Significant Drug Interactions
Berberine is pharmacologically potent, which means it has a meaningful interaction profile. GI distress (cramping, diarrhea, nausea) is the most common side effect, affecting 10-20% of users at starting doses. Start low (500mg/day) and titrate. Berberine is a significant CYP3A4 and CYP2D6 inhibitor — meaning it can raise blood levels of drugs metabolized by these enzyme families, including statins, certain antidepressants, beta-blockers, calcium channel blockers, and many others.
CRITICAL WARNING — Berberine Drug Interactions: Berberine inhibits CYP3A4 and CYP2D6, which together metabolize approximately 50% of all prescription drugs. If you take ANY prescription medication, consult your pharmacist before adding berberine. Specific high-risk combinations: berberine + metformin (additive hypoglycemia), berberine + statins (increased statin blood levels and myopathy risk), berberine + cyclosporine (dangerously elevated cyclosporine levels). Do NOT combine berberine with metformin without medical supervision.
CoQ10 — Warfarin Interaction
CoQ10 is very well-tolerated. The primary interaction concern is with warfarin: CoQ10 has a chemical structure similar to vitamin K and may reduce warfarin's anticoagulant effect. Individuals on warfarin should have INR monitored when starting or stopping CoQ10. Beyond this, CoQ10 has an excellent safety profile at doses up to 1200mg/day in clinical trials.
Astaxanthin — Very Safe
Astaxanthin has one of the cleanest safety profiles of any supplement compound. No significant drug interactions have been identified. Side effects are limited to mild GI discomfort and a harmless orange-red discoloration of stool at high doses (it is a carotenoid pigment). The FDA has granted GRAS (Generally Recognized as Safe) status to astaxanthin from Haematococcus pluvialis.
- Berberine + prescription drugs: CYP3A4/2D6 inhibition — consult pharmacist for ANY medication
- Berberine + metformin: additive hypoglycemia risk — medical supervision required
- Quercetin + thyroid: monitor TSH if supplementing long-term at high doses
- Resveratrol + anticoagulants: mild platelet inhibition — monitor if on blood thinners
- CoQ10 + warfarin: may reduce warfarin efficacy — monitor INR
- NMN/NR + active cancer: theoretical concern (NAD+ fuels all cells) — consult oncologist
- Start berberine at 500mg/day and titrate slowly to manage GI tolerance
For Physique Enhancement — Longevity Meets Performance
This is not a performance stack. It is a longevity and healthspan stack that happens to have several downstream benefits for physique-oriented individuals. The distinction matters: do not expect acute ergogenic effects comparable to creatine, caffeine, or citrulline. Instead, expect long-term optimization of the biological systems that support training capacity and recovery.
NAD+ and Training Capacity
Mitochondrial function directly determines aerobic capacity, recovery rate between sets, and ability to sustain high training volumes over weeks and months. NAD+ decline impairs mitochondrial oxidative phosphorylation — restoring NAD+ supports the energy systems that fuel training. This effect is gradual, not acute. You will not feel NMN in a single session; you may notice improved recovery and sustained performance over months.
Berberine and Body Composition
Berberine's AMPK activation improves insulin sensitivity and glucose disposal — directing nutrients toward muscle glycogen rather than adipose storage. For individuals in a body recomposition phase, berberine acts as a nutrient-partitioning agent. The glucose-lowering effect is clinically significant (comparable to metformin). Caution: if you train fasted or follow a low-carbohydrate diet, berberine's glucose-lowering effect could cause hypoglycemia during training. Take with meals.
CoQ10 and Cardiac Output
CoQ10 supports cardiac muscle mitochondria — improving exercise tolerance and cardiac output in individuals with suboptimal CoQ10 status (common over age 40, especially in statin users). Clinical trials in heart failure patients show improved exercise capacity with CoQ10 supplementation. Healthy younger athletes are less likely to benefit unless CoQ10 levels are depleted.
Astaxanthin and Exercise-Induced Oxidative Stress
Intense training generates significant ROS. While some exercise-induced ROS is necessary for adaptive signaling (the hormesis effect), excessive or sustained oxidative stress impairs recovery. Astaxanthin reduces exercise-induced DNA damage (8-OHdG) and inflammatory markers post-training without blunting the adaptive training response — unlike high-dose vitamin C/E, which can impair training adaptations.
Quercetin and Recovery
Quercetin's NF-kB inhibition reduces systemic inflammation that impairs recovery between sessions. It also has mild anti-histamine properties that may reduce exercise-induced bronchoconstriction. The effect on recovery is modest compared to dedicated recovery compounds but contributes to the stack's overall anti-inflammatory profile.
Physique Bottom Line: This stack is an insurance policy for long-term biological function, not an acute performance enhancer. The benefits to physique-oriented individuals are real but indirect — better mitochondrial function, improved metabolic health, reduced chronic inflammation, and faster recovery. If you are under 30 and focused purely on performance, this stack is premature. If you are over 35 and training for longevity alongside physique goals, it becomes increasingly relevant.
For Cognitive Enhancement — Brain Aging Defense
The brain is disproportionately vulnerable to aging. It represents 2% of body mass but consumes 20% of total oxygen and metabolic energy. Neuronal mitochondria operate at near-maximum capacity, making them extremely sensitive to NAD+ decline, oxidative damage, and metabolic dysregulation. This stack addresses multiple axes of brain aging.
NAD+ and Neuronal Energy
The brain's enormous metabolic demand means NAD+ decline hits neurons early and hard. Reduced NAD+ impairs neuronal ATP production, DNA repair (via PARPs), and sirtuin-mediated neuroprotective pathways. NMN crosses the blood-brain barrier in animal models and restores brain NAD+ levels. In aged mice, NMN improved cerebrovascular function, neurovascular coupling (the mechanism by which blood flow increases to active brain regions), and cognitive performance. Human brain NAD+ data from NMN is still limited but consistent with peripheral biomarker improvements.
Astaxanthin and Neuroprotection
Astaxanthin is one of the few antioxidants confirmed to cross the blood-brain barrier. It accumulates in brain tissue and protects neuronal membranes — the lipid-rich structures that are particularly vulnerable to peroxidation. In animal models, astaxanthin reduces neuroinflammation, protects against ischemic brain injury, and improves spatial learning and memory in aged mice. Its ability to protect mitochondrial membranes in the brain is particularly valuable given the brain's oxygen consumption rate.
Resveratrol and Cerebrovascular Function
Resveratrol improves cerebrovascular blood flow through multiple mechanisms: endothelial nitric oxide synthase (eNOS) upregulation, SIRT1-mediated vascular protection, and direct antioxidant effects on the vasculature. In the Moussa 2017 Alzheimer's trial, resveratrol reduced MMP-9 (a marker of blood-brain barrier permeability), suggesting it may help maintain BBB integrity — a critical factor in brain aging that deteriorates with age.
Quercetin and Neuroinflammation
Neuroinflammation driven by microglial activation and pro-inflammatory cytokines is a hallmark of brain aging and neurodegenerative disease. Quercetin inhibits NF-kB signaling in microglia, reducing neuroinflammatory cytokine production (IL-1beta, IL-6, TNF-alpha). Its senolytic activity may also clear senescent glial cells that contribute to the neuroinflammatory environment. Quercetin crosses the BBB at low levels — enough for anti-inflammatory effects but not for potent senolytic concentrations in brain tissue.
CoQ10 and Brain Mitochondrial Function
Brain mitochondria are highly susceptible to age-related dysfunction because neurons are post-mitotic (they cannot be replaced) and have enormous ATP demands. CoQ10 supports electron transport chain efficiency in neuronal mitochondria, reducing electron leak and the resulting oxidative damage. Clinical evidence for cognitive effects is strongest in neurodegenerative conditions (Parkinson's disease trials), but the underlying mechanism — maintaining mitochondrial function in aging neurons — is relevant to normal brain aging.
Cognitive Bottom Line: This stack provides multi-layer neuroprotection — NAD+ restoration for neuronal energy, astaxanthin for BBB-penetrating antioxidant defense, resveratrol for cerebrovascular support, quercetin for neuroinflammation reduction, and CoQ10 for mitochondrial maintenance. These are not acute cognitive enhancers (you will not feel sharper after a single dose). They are long-term investments in brain structural and functional integrity. For acute cognitive performance, see our analyses of Alpha-GPC, Lion's Mane, and L-Theanine.
Conclusions & Evidence-Based Protocols
Protocol Summary
The Longevity & NAD+ Restoration Stack is the most ambitious and most expensive protocol in the Protocols.is framework. It targets six hallmarks of aging through six synergistic compounds, each with distinct mechanisms and complementary interactions. The mechanistic logic is strong. The animal data is compelling. The human data is emerging but incomplete.
The Sinclair Protocol Context
This stack is partially inspired by the regimen David Sinclair, PhD, has publicly discussed: NMN + resveratrol + metformin as the core of his personal longevity approach. We retain the NMN + resveratrol core (the NAD+/sirtuin axis), substitute berberine for metformin (available without prescription, similar AMPK mechanism), and add three additional agents to expand coverage: quercetin for senolytic activity, CoQ10 for mitochondrial ETC support, and astaxanthin for membrane-level antioxidant protection. This provides broader hallmark coverage than the Sinclair core while remaining accessible without a prescription.
Priority Hierarchy (If Budget Is Limited)
- Tier 1 (core duo): NMN or NR + Resveratrol — the NAD+/sirtuin axis. This is the minimum effective longevity stack. ~$60-120/month.
- Tier 2 (add metabolic support): + Berberine — AMPK activation, NAMPT upregulation, metabolic health. ~$70-140/month.
- Tier 3 (add mitochondrial protection): + CoQ10 (ubiquinol) — ETC maintenance, cardiovascular aging. ~$90-170/month.
- Tier 4 (full stack): + Quercetin + Astaxanthin — senolytic activity, membrane antioxidant. ~$100-200/month.
Biomarkers to Track
If you invest in this stack, track the biomarkers it targets. Clinically indicated testing every 3-6 months:
- Metabolic panel: Fasting glucose, fasting insulin, HbA1c, HOMA-IR (insulin resistance index)
- Inflammatory markers: hs-CRP, IL-6, TNF-alpha (if available)
- Lipid panel: Total cholesterol, LDL, HDL, triglycerides, ApoB
- NAD+ metabolites: Available through specialty labs (e.g., Jinfiniti) — measures intracellular NAD+ levels
- Liver and kidney function: ALT, AST, GGT, creatinine, BUN (monitoring berberine and overall stack safety)
- Thyroid panel: TSH, free T3, free T4 (if taking quercetin long-term)
- Biological age testing (optional): Epigenetic clocks (TruAge, GrimAge) for a composite aging biomarker
Frequently Asked Questions
Partially inspired by. David Sinclair, PhD, has publicly discussed taking NMN, resveratrol, and metformin as the core of his personal longevity regimen. This stack retains the NMN + resveratrol core (the NAD+/sirtuin axis) but substitutes berberine for metformin — berberine activates AMPK through a similar mechanism and is available without a prescription. We also expand coverage by adding quercetin (senolytic), CoQ10 (mitochondrial ETC support), and astaxanthin (membrane antioxidant) to address hallmarks of aging that the Sinclair core does not directly target. It is an evolution of the concept, not a copy.
Both raise NAD+ levels. NR (nicotinamide riboside) has more published human clinical data, including the Martens 2018 RCT showing improved arterial compliance and reduced blood pressure. NMN (nicotinamide mononucleotide) is one enzymatic step closer to NAD+ in the salvage pathway and may be more direct, but head-to-head human comparisons are lacking. The Yi 2023 NMN trial showed improved muscle insulin sensitivity. Neither is clearly superior based on current evidence. NR is generally less expensive per effective dose. Choose based on availability, cost, and personal response. Some practitioners suggest trying each for 2-3 months and comparing subjective and biomarker outcomes.
Unknown. This is the honest answer that any responsible source must give. No human lifespan data exists for any of these compounds. The stack targets biomarkers associated with aging — NAD+ levels, inflammatory markers, mitochondrial function, senescent cell burden, metabolic health, and oxidative stress. Improvements in these biomarkers correlate with healthier aging in observational studies and animal models. Quercetin + dasatinib extended remaining lifespan by 36% in aged mice. NMN reversed vascular aging markers in mouse models. But extrapolating from biomarkers and animal models to human lifespan is a leap of inference, not a proof. This stack is a best-available-evidence bet, not a guarantee.
This is a theoretical concern that has not been demonstrated in humans. The logic: NAD+ is required by all cells, including cancer cells. Some tumor types upregulate NAD+ biosynthesis. Raising systemic NAD+ could theoretically provide fuel to undetected tumors. However, NAD+ also fuels PARPs (DNA repair enzymes that prevent cancer initiation) and immune surveillance mechanisms that detect and destroy cancer cells. No human trial of NMN or NR has shown increased cancer incidence. The concern is actively debated among longevity researchers. If you have active cancer or a recent cancer history, consult your oncologist before supplementing with NAD+ precursors. For healthy individuals, the current risk-benefit assessment does not support avoiding NMN/NR on this basis.
Not without medical supervision. Both berberine and metformin lower blood glucose through AMPK activation and improved insulin sensitivity. Combining them creates additive (or potentially synergistic) glucose-lowering effects, which significantly increases hypoglycemia risk — especially in individuals who are not severely insulin resistant. Symptoms of hypoglycemia include dizziness, confusion, shakiness, sweating, and in severe cases, loss of consciousness. If you are currently prescribed metformin, do not add berberine without consulting your physician. They may adjust your metformin dose, suggest choosing one over the other, or monitor your blood glucose more frequently during a combination trial.
That depends on your health priorities, your age, and your budget. This is the most expensive protocol in our analysis at $100-200 per month for the full six-compound stack. NMN alone is $50-100/month. Before investing in supplements, ensure your foundations are in place: consistent exercise is the single most evidence-backed longevity intervention; adequate sleep (7-9 hours), whole-food nutrition, and stress management are next. If those foundations are solid and you have disposable income for optimization, this stack targets multiple aging pathways with reasonable mechanistic evidence. If budget is limited, start with Tier 1 (NMN or NR + resveratrol) at ~$60-120/month and add compounds over time as budget allows. Do not sacrifice food quality or gym membership for supplements.
Begin in the app
Share your biology. Receive a precision protocol routed through hundreds of cited compounds.